NBIX vs. VOO
Compare and contrast key facts about Neurocrine Biosciences, Inc. (NBIX) and Vanguard S&P 500 ETF (VOO).
VOO is a passively managed fund by Vanguard that tracks the performance of the S&P 500 Index. It was launched on Sep 7, 2010.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NBIX or VOO.
Key characteristics
| NBIX | VOO | |
|---|---|---|
| YTD Return | 8.55% | 5.63% |
| 1Y Return | 38.26% | 23.68% |
| 3Y Return (Ann) | 14.84% | 7.89% |
| 5Y Return (Ann) | 12.65% | 13.12% |
| 10Y Return (Ann) | 27.02% | 12.38% |
| Sharpe Ratio | 1.48 | 1.91 |
| Daily Std Dev | 25.26% | 11.70% |
| Max Drawdown | -97.21% | -33.99% |
| Current Drawdown | -0.49% | -4.45% |
Correlation
The correlation between NBIX and VOO is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
NBIX vs. VOO - Performance Comparison
In the year-to-date period, NBIX achieves a 8.55% return, which is significantly higher than VOO's 5.63% return. Over the past 10 years, NBIX has outperformed VOO with an annualized return of 27.02%, while VOO has yielded a comparatively lower 12.38% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NBIX vs. VOO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NBIX vs. VOO - Dividend Comparison
NBIX has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.39%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VOO Vanguard S&P 500 ETF | 1.39% | 1.46% | 1.69% | 1.25% | 1.54% | 1.88% | 2.06% | 1.78% | 2.02% | 2.10% | 1.85% | 1.84% |
Drawdowns
NBIX vs. VOO - Drawdown Comparison
The maximum NBIX drawdown since its inception was -97.21%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for NBIX and VOO. For additional features, visit the drawdowns tool.
Volatility
NBIX vs. VOO - Volatility Comparison
Neurocrine Biosciences, Inc. (NBIX) has a higher volatility of 7.79% compared to Vanguard S&P 500 ETF (VOO) at 3.89%. This indicates that NBIX's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.